Table 3.
Comparison between the lymphoma group and patients with other malignancies
| Lymphoma (N = 64) | Patients with other malignancies (N = 128) | P | |
|---|---|---|---|
| Age (years) | 30.32 ± 4.98 | 32.51 ± 4.58 | 0.002 |
| Age (years)a | 30.5 (28–34) | 33 (30–36) | 0.002b |
| Body mass index (kg/m2) | 20.54 ± 8.17 | 21.5 ± 6.29 | 0.36 |
| AMH (ng/mL) | 1.08 ± 0.74 | 2.21 ± 1.62 | <0.001 |
| AFC (number of follicles) | 9.41 ± 4.77 | 12.03 ± 4.26 | <0.001 |
| LH at start of stimulation (mIU/mL) | 5.69 ± 3.04 | 4.91 ± 4.24 | 0.19 |
| No. of days of COH | 10.03 ± 2.20 | 10.92 ± 2.17 | 0.01 |
| Total gonadotropins used (units) | 3254.89 ± 1426.83 | 3332.14 ± 1543.21 | 0.73 |
| No. of patients receiving HCG trigger (%) | 58 (90.63) | 115 (89.84) | 0.88 |
| No. of patients receiving dual trigger (%) | 4 (6.25) | 9 (7.03) | 0.99* |
| No. of patients receiving leuprolide acetate only trigger (%) | 2 (3.12) | 4 (3.13) | 0.99* |
| No. of harvested oocytes | 10.81 ± 6.49 | 13.91 ± 8.99 | 0.01 |
| No. of frozen oocytes | 8.12 ± 5.54 | 10.67 ± 7.61 | 0.01 |
| Patients who started COH in luteal phase (%) | 4 (6.25) | 15 (11.72) | 0.35* |
| Used OCPs immediately prior to COH (%) | 9 (14.06) | 10 (7.81) | 0.19 |
Values are expressed as mean ± SD unless otherwise specified
*Fisher’s exact test
aMedian and interquartile range
bMann-Whitney U